Choline metabolism in malignant transformation
Open accessThe DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
Abnormal choline metabolism is emerging as a metabolic hallmark that is associated with oncogenesis and tumour progression. Following transformation, the modulation of enzymes that control anabolic and catabolic pathways causes increased levels of choline-containing precursors and breakdown products of membrane phospholipids. These increased levels are associated with proliferation, and recent studies emphasize the complex reciprocal interactions between oncogenic signalling and choline metabolism. Because choline-containing compounds are detected by non-invasive magnetic resonance spectroscopy (MRS), increased levels of these compounds provide a non-invasive biomarker of transformation, staging and response to therapy. Furthermore, enzymes of choline metabolism, such as choline kinase, present novel targets for image-guided cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
THE FUNCTION OF CYTIDINE COENZYMES IN THE BIOSYNTHESIS OF PHOSPHOLIPIDES
Kennedy, E. P., & Weiss, S. B. (1956) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50785-2 · Cited by 1,810
Phosphatidylcholine breakdown and signal transduction
Exton, J. H. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90186-4 · Cited by 960
Studies of human tumors by MRS: A review
Negendank, W. (1992) · NMR in Biomedicine · doi:10.1002/nbm.1940050518 · Cited by 660
Aboagye, E. O., & Bhujwalla, Z. M. (1999) · PubMed · Cited by 596
Self-citationMRI of the tumor microenvironment
Gillies, R. J., Raghunand, N., Karczmar, G. S., & Bhujwalla, Z. M. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10181 · Cited by 550
Self-citationCharacterization of Two Alternately Spliced Forms of Phospholipase D1
Hammond, S. M., Jenco, J. M., Nakashima, S., Cadwallader, K., Gu, Q.-M., Cook, S., Nozawa, Y., Prestwich, G. D., Frohman, M. A., & Morris, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3860 · Cited by 541
Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.
Lerner, L. J., & Jordan, V. C. (1990) · PubMed · Cited by 417
Bruhn, H., Frahm, J., Gyngell, M. L., Merboldt, K. D., Hänicke, W., Sauter, R., & Hamburger, C. (1989) · Radiology · doi:10.1148/radiology.172.2.2748837 · Cited by 397
Molecular Causes of the Aberrant Choline Phospholipid Metabolism in Breast Cancer
Glunde, K., Jie, C., & Bhujwalla, Z. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3829 · Cited by 380
Self-citation
Cited by
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
“Many cancers have increased PC levels and increased activity of any of several enzymes in the PC synthesis pathway, while 158 Cell Metabolism 18, August 6, 2013 ª2013 Elsevier Inc. inhibition or knockdown of many of the enzymes decreases cancer phenotypes (Glunde et al., 2011).”
BackgroundSerine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity
Yoon, H., Shaw, J. L., Haigis, M. C., & Greka, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.027 · Cited by 510
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z.-J., Xi, M.-J., Xia, B.-H., Deng, K., & Yang, J.-L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 481
Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis
Bustamante, M. F., Garcia-Carbonell, R., Whisenant, K. D., & Guma, M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1303-3 · Cited by 407
Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS
Wang, J., Zhang, T., Shen, X., Liu, J., Zhao, D., Sun, Y., Wang, L., Liu, Y., Gong, X., Liu, Y., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1050-5 · Cited by 373
Keshari, K. R., & Wilson, D. M. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60124b · Cited by 358
Radiotherapy planning using MRI
Schmidt, M. A., & Payne, G. S. (2015) · Physics in Medicine and Biology · doi:10.1088/0031-9155/60/22/r323 · Cited by 357
The role of phosphatidylcholine and choline metabolites to cell proliferation and survival
Ridgway, N. D. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.735643 · Cited by 339
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Shukla, S. K., Gebregiworgis, T., Purohit, V., Chaika, N. V., Gunda, V., Radhakrishnan, P., Mehla, K., Pipinos, I. I., Powers, R., Yu, F., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-18 · Cited by 255
Bae, S., Ulrich, C. M., Neuhouser, M. L., Malysheva, O., Bailey, L. B., Xiao, L., Brown, E. C., Cushing-Haugen, K. L., Zheng, Y., Cheng, T.-Y. D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1835 · Cited by 253
Ortmayr, K., Dubuis, S., & Zampieri, M. (2019) · Nature Communications · doi:10.1038/s41467-019-09695-9 · Cited by 142
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism
Izquierdo-Garcia, J. L., Viswanath, P., Eriksson, P., Cai, L., Radoul, M., Chaumeil, M. M., Blough, M., Luchman, H. A., Weiss, S., Cairncross, J. G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0840 · Cited by 123
“This observation is counter to the increase in PC and drop inGPC typically observed in cancer (18) and possibly points to metabolic alterations unique to mutant IDH1 tumors.”
ResultSelf-citationGuertin, K. A., Li, X. S., Graubard, B. I., Albanes, D., Weinstein, S. J., Goedert, J. J., Wang, Z., Hazen, S. L., & Sinha, R. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0948 · Cited by 96
“Increased total choline-containing compounds, referred to as the "colonic phenotype," is a recently identified metabolic hallmark of malignant transformations (31).”
BackgroundRamamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
“PET imaging of extracellular pH in tumors with (64)Cu- and (18) F-labeled pHLIP peptides: a structure-activity optimization study.”
BackgroundJabalera, Y., Sola-Leyva, A., Peigneux, A., Vurro, F., Iglesias, G. R., Vilchez-Garcia, J., Pérez-Prieto, I., Aguilar-Troyano, F. J., López-Cara, L. C., Carrasco-Jiménez, M. P., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080408 · Cited by 27
Metadata
- Authors
- Glunde, K., Bhujwalla, Z. M., & Ronen, S. M.
- Venue
- Nature Reviews Cancer
- Published
- 2011-11-17
- Volume
- 11
- Issue
- 12
- Pages
- 835-848
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2083166156
- Cited by
- 823
- References
- 135
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.